Marco Chiostri
Overview
Explore the profile of Marco Chiostri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
138
Citations
850
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Granchietti A, Ciardetti N, Mazzoni C, Garofalo M, Mazzotta R, Micheli S, et al.
Int J Cardiol
. 2025 Jan;
422:132981.
PMID: 39805543
Aim: Postoperative Atrial Fibrillation (POAF) is a common complication following Coronary Artery Bypass Grafting (CABG), associated with increased morbidity and mortality. Aim of the study is to analyze whether the...
2.
Capobianco T, Iannotti W, Agostini R, Persiani L, Chiostri M, Baldereschi G, et al.
Cureus
. 2023 Nov;
15(10):e46754.
PMID: 37946883
Introduction: In 2020, the SARS-CoV-2 pandemic outbreak required restrictive measures to limit the spread of the virus. This study aimed to assess how changes in dietary habits and lifestyle associated...
3.
Lazzeri C, Bonizzoli M, Batacchi S, Cianchi G, Franci A, Socci F, et al.
World J Cardiol
. 2023 May;
15(4):165-173.
PMID: 37124973
Background: The prognostic role of right ventricle dilatation and dysfunction (RVDD) has not been elucidated in patients with coronavirus disease (COVID)-related respiratory failure refractory to standard treatment needing extracorporeal membrane...
4.
Lazzeri C, Bonizzoli M, Batacchi S, Cianchi G, Franci A, Socci F, et al.
J Cardiothorac Vasc Anesth
. 2023 Apr;
37(7):1208-1212.
PMID: 37019701
Objectives: The study authors hypothesized that in patients with SARS-CoV-2, COVID-19-related refractory respiratory failure requiring extracorporeal membrane oxygenation (ECMO) support echocardiographic findings (just before ECMO implantation) would be different from...
5.
Lazzeri C, Bonizzoli M, Batacchi S, Chiostri M, Peris A
Am Heart J Plus
. 2022 Jul;
18:100178.
PMID: 35856066
Study Objectives: To assess whether echocardiography, systematically performed, could help in risk stratifying patients with acute respiratory distress syndrome (ARDS) due to SARS-CoV2 (COVID) infection for non invasive ventilation (NIV)...
6.
Lazzeri C, Bonizzoli M, Batacchi S, Cianchi G, Chiostri M, Socci F, et al.
Angiology
. 2022 Jun;
74(3):268-272.
PMID: 35722971
We assessed whether right ventricle (RV) alterations and their development may have clinical significance in critically-ill Coronavirus Disease (COVID) patients, as detected by serial echocardiograms during Intensive Care Unit (ICU)...
7.
Lazzeri C, Bonizzoli M, Batacchi S, di Valvasone S, Chiostri M, Peris A
Diabetes Res Clin Pract
. 2021 Apr;
175:108789.
PMID: 33812902
Aims: Due to heterogeneity on the prognostic role of glucose values and glucose variability in Novel Coronavirus (COVID) disease, we aimed at assessing the prognostic role for Intensive Care Unit...
8.
Giglioli C, Marchionni N, Mattesini A, Zocchi C, Biagioli M, Chiostri M, et al.
Acta Med Acad
. 2021 Mar;
49(3):265-277.
PMID: 33781070
Objective: The SYNTAX trial was designed to evaluate whether multivessel disease patients could benefit from percutaneous or surgical revascularization using a paclitaxel eluting stents, but after the introduction of second...
9.
Giglioli C, Cecchi E, Stefano P, Spini V, Fortini G, Chiostri M, et al.
J Cardiovasc Thorac Res
. 2021 Jan;
12(4):313-320.
PMID: 33510881
Studies have shown that a hemodynamic-guided therapy improves the post operative outcomes of high-risk patients.This study, evaluated if a short period through minimally invasive hemodynamic monitoring, pressure recording analytical method...
10.
Morelli A, Romano S, Sanfilippo F, Santonocito C, Frati G, Chiostri M, et al.
Br J Anaesth
. 2020 Jul;
125(6):1018-1024.
PMID: 32690246
Background: During sepsis, heart rate (HR) reduction could be a therapeutic target, but identification of responders (non-compensatory tachycardia) and non-responders (compensatory for 'fixed' stroke volume [SV]) is challenging. We tested...